Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis

by Florentia Dimitriou, Ramon Staeger, Melike Ak, Matias Maissen, Ken Kudura, Marjam J. Barysch, Mitchell P. Levesque, Phil F. Cheng, Reinhard Dummer, Joanna Mangana
Published 2021-06-01